# Pramlintide. AC 137, ACO 137, Normylin, Symlin, Tripro-amylin.

> PubMed lists PMID 10820656 in Drugs in R&D as Journal Article, with publication-date metadata of 1999-08 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-10820656-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-10-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-10820656-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-10820656-pramlintide-v1.json
- Content SHA-256: `ac34a673261294bfe9827a8055b9e06b029b7b2326c63ae2f6384a8fde132689`

## Claims and source pins

### Headline

Pramlintide. AC 137, ACO 137, Normylin, Symlin, Tripro-amylin. ([`pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e`](#source-pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e))

### Summary

PubMed lists PMID 10820656 in Drugs in R&D as Journal Article, with publication-date metadata of 1999-08 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e`](#source-pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e))

### Paragraph 1

PubMed lists PMID 10820656 in Drugs in R&D as Journal Article, with publication-date metadata of 1999-08 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e`](#source-pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e`](#source-pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e))

## Sources

<a id="source-pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e"></a>
- **Pramlintide. AC 137, ACO 137, Normylin, Symlin, Tripro-amylin. · retained source version 1:2018-10-25:current:f5b06799125e81a9737603debfd9fceb63c724b6613e9c70f8d5bc8ab9e9911e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/10820656/) (`pubmed-observation-pmid-10820656-2018-10-25-f5b06799125e`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Pramlintide. AC 137, ACO 137, Normylin, Symlin, Tripro-amylin." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-10820656-pramlintide-v1.json SHA-256: ac34a673261294bfe9827a8055b9e06b029b7b2326c63ae2f6384a8fde132689.